Zydus Lifesciences Gets US FDA’s Approval for Making Breast Cancer Medicine
Zydus Lifesciences has got approval from the US FDA to make a medicine called Palbociclib. The US FDA is a government agency in America that checks if medicines are safe and effective. Palbociclib is a medicine that helps to stop the growth of cancer cells in the breast. It is used along with other medicines to treat a certain type of breast cancer.
Palbociclib is a very important medicine because it can help many people who have breast cancer. It is also very expensive because it is made by a special process. It is not easy to make this medicine. Only a few companies in the world can make it.
Zydus Lifesciences is one of them. It has got permission from the US FDA to make Palbociclib tablets of different strengths: 75 mg, 100 mg, and 125 mg. This means that Zydus Lifesciences can sell these tablets in America and other countries where the US FDA’s approval is accepted.
This is good news for Zydus Lifesciences because it can earn more money by selling these tablets. It is also good news for people who have breast cancer because they can get this medicine at a lower price. Palbociclib has annual sales of $3.3 billion in America.
This is also good news for people in India who have breast cancer. According to the cancer registry in India, around 14 lakh new breast cancer patients get diagnosed yearly. This means that many people need this medicine to treat their disease.
Zydus Lifesciences can make this medicine in India because it has been off-patent in India since the last 6 months. This means that no one has the exclusive right to make this medicine in India anymore. Other generic sellers include Dr. Reddy’s and Sun Pharma.
With Zydus getting manufacturing approval from US FDA, it gives them an edge to cater to this large market. This means that they can make more quality and affordable medicines for people who have breast cancer.
The outlook for Zydus Lifesciences is positive because it has shown its ability to make complex and useful medicines for people who need them. It has also shown its commitment to improving the health and well-being of people around the world.
Keywords : Zydus, US FDA, Breast cancer, Palbociclib, High-demand